Search

everythinglearnresearchcommunity

for

Search:↓

Researchers successfully isolated and identified key markers of stem cell-enriched human hair follicle bulge cells.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

TSH is usually the only test needed to check thyroid function in primary care.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.